SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to speculation surrounding its potential inclusion in the S&P 500, sparking bullish sentiment and driving conversations about the potential "index effect" and forced ETF buying. The community is actively discussing strategies around options and covered calls, while also weighing the potential for a "sell the news" reaction post-inclusion. Some are comparing Robinhood to other stocks that were added to the S&P 500.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as traders discuss the potential for inclusion in the S&P 500, though sentiment is mixed. The community debates whether it deserves inclusion as a bitcoin proxy, with some suggesting its fate is tied to bitcoin's price action, while others eye a potential sell-off if it's excluded. Discussions also involve covered call strategies and comparisons to other stocks added to the index.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming airdrops and staking opportunities. The coin's growing watcher count and bullish sentiment are fueling discussions about potential market cap milestones and ongoing buy contests. Community members express excitement about the project's long-term vision, developments and transparency.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending due to its impending addition to the S&P 500, driving forced ETF buying and increased liquidity, though some traders are anticipating a short-term pullback following the inclusion. Community discussions revolve around the potential for new all-time highs and the long-term implications of S&P 500 membership, with some skepticism regarding short reports from firms like Muddy Waters.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG.X) is trending as the community rallies around its unique rewards system, which distributes Solana ($SOL.X) directly to holders, regardless of price fluctuations. Recent discussions highlight the strength and resilience of the community, with many emphasizing that holding $IMG.X provides passive income superior to traditional investments, while also mentioning a new partnership with Kimbo Slice Jr.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group Inc. is trending as the community debates the impact of its recent reverse stock split and a closed investment deal with Uber. While some investors express optimism about the company's technology and long-term potential, others are concerned about cash burn and dilution, contributing to a volatile stock price. Discussions also revolve around the company's management and future prospects within the competitive EV sector.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is trending due to speculation surrounding its potential inclusion in the S&P 500, with community members actively discussing the possibility and implications. Despite some disappointment over recent news, the stock is experiencing a surge in interest following a new partnership with Josh Allen and positive analyst ratings. Bullish investors express optimism for continued growth, while others remain cautious about valuation and potential dilution.

THE COQ FATHER BOSS

$BOSSCOQ.X is trending as the community discusses its potential and compares it to other meme coins. The coin is being mentioned alongside other crypto symbols, indicating interest in its growth within the meme coin sector. Community members are actively expressing their preference for $BOSSCOQ.X over similar coins.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF ($MSTY) is trending as investors discuss its recent performance, particularly in relation to MicroStrategy ($MSTR) and Bitcoin. Concerns are emerging regarding NAV erosion and the sustainability of dividend payouts, with some community members expressing bearish sentiment. Others remain optimistic, viewing dips as buying opportunities and emphasizing the potential for high yield and long-term gains, especially if $MSTR is included in the S&P 500.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending due to reports linking Tylenol use during pregnancy to autism, sparking debate among investors and drawing attention to potential legal ramifications. While some dismiss the claims as overblown and see a buying opportunity, others express concern and anticipate further declines. Community discussions also involve the stock's dividend yield and potential recovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vera Therapeutics stock sinks following competitor’s successful trial

Investing.com -- Shares of  Vera Therapeutics  (NASDAQ:VERA) tumbled by 33% in premarket trading today after a Japanese competitor, Otsuka, reported positive results from a Phase 3 trial of a competing kidney disease therapy. Otsuka’s announcement indicated that its drug, sibeprenlimab, achieved a 51.2% reduction in proteinuria in the treatment of immunoglobulin A nephropathy (IgAN), surpassing the results from Vera’s own candidate, atacicept.

Shares of Vera Therapeutics, Inc. (VERA) were in the spotlight on Tuesday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.veratx.com/news-releases/news-release-details/vera-therapeutics-announces-refinancing-existing-oxford-debt">announced</a> that it has entered into a new credit facility providing for up to $500 million of term loans with its current partner, Oxford Finance LLC.The new credit facility will replace Vera’s existing $50 million credit facility. The initial funding of the new credit facility will be in a principal amount of $75 million and is expected to occur on June 4, 2025, the company said.The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated.Vera Therapeutics is looking to submit a Biologics License Application to the U.S. Food and Drug Administration in the fourth quarter of this year for Atacicept. The company is looking forward to the potential commercialization of the investigational drug for the treatment of immunoglobulin A nephropathy (IgAN) in adults.IgA nephropathy, also known as Berger's disease, is a kidney disease where antibodies build up in the kidneys, causing inflammation and damage.Vera on Monday said that Atacicept achieved a 46% reduction from baseline in protein levels in the urine of 431 adults with IgA nephropathy being evaluated in a late-stage trial.VERA stock closed 67% higher on Monday on the news.On Stocktwits, retail sentiment around VERA stayed unmoved within the ‘extremely bullish’ territory over the past 24 hours while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:624/68;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_03_at_8_05_39_AM_png_bf7adee158.webp" alt="VERA's Sentiment Meter and Message Volume as of 8:05 a.m. ET on June 3, 2025 | Source: Stocktwits" width="624" height="68"><figcaption>VERA's Sentiment Meter and Message Volume as of 8:05 a.m. ET on June 3, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user praised the company’s decisions.<stembedurl>https://stocktwits.com/US_Bull/message/616604119</stembedurl>Another expects the stock will hit $40 soon.<stembedurl>https://stocktwits.com/tomf95/message/616602882</stembedurl><a href="https://stocktwits.com/symbol/VERA">VERA stock</a> is down by 25% this year and by about 21% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/weride-partners-with-renault-for-autonomous-shuttle-service-at-the-french-open/chkr56IRbvO">WeRide Partners With Renault To Provide Autonomous Shuttle At The French Open, But Retail’s Not Excited</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Vera Therapeutics Enters $500M Credit Facility As It Nears FDA Filing For Kidney Disease Drug: Retail Sees Stock Touching $40

The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated.

Equity

The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated.


Commit To Buy Vera Therapeutics At $25, Earn 12.7% Annualized Using Options

Investors eyeing a purchase of Vera Therapeutics Inc (VERA) shares, but cautious about paying the going market price of 38.14/share, might benefit from considering selling puts among the...

Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress

72-week data of atacicept in IgAN accepted as a best-ranked abstract Analysis of impact of atacicept on hematuria in IgAN accepted as a focused oral presentation BRISBANE, Calif., April 02...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vera Therapeutics (VERA Research Report), Tyra Bioscience (TYRA...

Vera Therapeutics reports FY23 EPS ($2.25) vs ($3.35) last year

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatmentActively adding sites and...

Vera Therapeutics (VERA, $44.19) Aroon Indicator entered an Uptrend on March 12, 2024.

Over the last three days, A.I.dvisor has detected that VERA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Vera Therapeutics (VERA, $43.15) Aroon Indicator entered an Uptrend on March 11, 2024.

Vera Therapeutics (VERA, $44.3) Aroon Indicator entered an Uptrend on March 08, 2024.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

VERA
Vera Therapeutics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VERA News

VERA Vera Therapeutics Inc - Ordinary Shares - Class A